New dengue vaccine delivery method shows promise in small trial
NCT ID NCT06837116
First seen Jan 18, 2026 · Last updated May 24, 2026 · Updated 24 times
Summary
This pilot study tested a dengue vaccine called Qdenga given under the skin (intradermal) in 29 healthy Thai adults aged 18-60. The goal was to measure the body's immune response and safety over 120 days. The study is complete and provides early data on this vaccine delivery method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, 90110, Thailand
-
Prince of Songkla university
Hat Yai, Changwat Songkhla, 90110, Thailand
Conditions
Explore the condition pages connected to this study.